Oocyte in vitro maturation in normo-ovulatory women.

Objective: To review the scientific literature concerning the application of oocyte in vitro maturation (IVM) as a treatment for normo-ovulatory women.

Design: Critical evaluation and comparison of the most relevant clinical studies.

Setting: Public IVF unit.

Anti-mullerian hormone as a predictive marker for the selection of women for oocyte in vitro maturation treatment.

Purpose: In oocyte in-vitro maturation (IVM) treatments, the chances to achieve a pregnancy are critically dependent on the retrieval of a suitable number of oocytes. In this study, we assessed the ability of circulating levels of anti-mullerian hormone (AMH) to identify normo-ovulatory women suitable for IVM treatment on the basis of the number of retrieved oocytes.

Method: Serum AMH was quantified in normo-ovulatory women younger than 39 years undergoing IVM treatment.